AFP-L3 and DCP Strongly Predict Early Hepatocellular Carcinoma Recurrence After Liver Transplantation. Norman JS, Li PJ, Kotwani P, Shui AM, et al. J Hepatol 2023 Sep 6:S0168-8278(23)05074-2. doi: 10.1016/j.jhep.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Norman JS, Li PJ, Kotwani P, Shui AM, et al. AFP-L3 and DCP Strongly Predict Early Hepatocellular Carcinoma Recurrence After Liver Transplantation. J Hepatol 2023 Sep 6:S0168-8278(23)05074-2. doi: 10.1016/j.jhep.2023.
PMID: 37683735